Theranosis Life Sciences Pvt Ltd

Theranosis Life Sciences Pvt Ltd is a personalized medicine startup addressing unmet needs in cancer diagnostics, prognostics and theranostics.

We are developing microfluidics based lab-on-a-chip medical devices that can detect rare cells such as circulating tumor cells in a simple blood sample drawn from a cancer patient (also known as liquid biopsy) for monitoring the treatment efficacy, predict clinical outcomes and post treatment follow up (surveillance) for cancer recurrence in the form of secondary metastasis.

Our patent pending advanced microfluidics chip is designed in such a way so as to capture specific populations of rare cells and perform downstream characterizations. It can be extended beyond cancer research, for example rare fetal cells in maternal blood circulation, circulating endothelial cells in atherosclerosis etc.

Research Collaborations: We invite anyone interested in evaluating our CTC platform for cancer research. Most common applications include isolation and enrichment of target cell population from peripheral blood. Live cells can be flushed out of the flow cell for downstream applications such as single cell genomics or transcriptomics. Ideal for drug discovery and development. If the patient has a good immune response then we can find CTC clusters which is a mixture of CTCs and activated lymphocytes that are reactive to neoantigens expressed by the circulating tumor cells. As of March 2019 we have tested our chip in NSCLC and breast cancer.

Disclaimer: We are not associated in any way with Theranos Inc., a USA company – the name similarity is due to the common usage of the keyword “theranosis”​

Origin of company name: Thera_nosis = Thera_py + Diag_nosis

Disclaimer (for In Vitro Diagnostics usage): Our platform is currently for “Research Use Only”​ – it has not yet been approved by the US FDA or CE – IVD or any other agency for IVD assay in the clinic.

For more details please get in touch with us:

Email: [email protected]

Company’s Keywords:

medical devices, cancer genomics, labonachip, cancer diagnostics, tumor immunotherapy, tumor microenvironment, circulating tumor cells, liquid biopsy, ctdna, circulating tumor exosomes, microbiome, metagenomics, ngs, nanoporesequencing